A controlled substance is a drug or chemical whose production, possession, or usage is regulated by the government. Some examples of these are: Marijuana, Cocaine, Morphine and others. These controlled drug are categorized in 5 classes: narcotics, stimulants, depressants, hallucinogens, and anabolic steroids. Opioid analgesics are FDA-approved and are used to treat moderate to severe pain.
MARKET DYNAMICS
The controlled substance is driving due to increasing prescription of controlled substance for cancer and rising use of opioids for pain management. Moreover, public awareness on use of controlled substances may create growth opportunities for the market.
MARKET SCOPE
The "Controlled Substance Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of controlled substance with detailed market segmentation by drug class, application, distribution channel. The controlled substance is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in controlled substance and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The controlled substance is segmented on the basis of drug class, application, and distribution channel. Based on drug class, the market is segmented as opioids, stimulants, depressants, and cannabinoids. The application segment is categorized into attention deficit hyperactivity disorder, pain management, depression, sleep disorder, cough suppression, anxiety, seizure, and others. The distribution channel segment is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the controlled substance based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The controlled substance by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting controlled substance from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Controlled substance in these regions.
MARKET PLAYERS
The report covers key developments in the controlled substance as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from controlled substance are anticipated to have lucrative growth opportunities in the future with the rising demand for controlled substance in the global market. Below mentioned is the list of few companies engaged in the controlled substance .
The report also includes the profiles of key players in controlled substance along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- F. Hoffmann-La Roche AG
- AbbVie, Inc.
- Mallinckrodt plc
- Pfizer, Inc.
- Sun Pharmaceuticals Ltd.
- Ampac Fine Chemicals
- GW Pharmaceuticals plc
- Merck & Co., Inc.
- Lannett
- Teva Pharmaceutical Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.